BioSpace News Archive

Medtronic plc, a global leader in healthcare technology, and OLV Hospital Aalst announced that the first clinical procedure in Europe was performed with the Hugo™ robotic-assisted surgery system.

Achieves 11% fourth quarter revenue growth as reported and 10.5% organic, driven by 13% CAG Diagnostics recurring revenue growth (reported and organic).

Tango Therapeutics, Inc., a biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, announced that members of the management team are scheduled to participate in the following upcoming virtual investor conferences in February.

Argonaut Manufacturing Services and n-Lorem, a nonprofit foundation, today announced a new partnership that supports and reduces the cost of manufacturing of n-Lorem’s experimental antisense oligonucleotide (ASO) medicines developed for nano-rare disease patients (1 to 30 patients worldwide) for free, for life.

Clearside Biomedical, Inc., a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space, announced that Clearside’s SCS injection platform featuring the SCS Microinjector® will be featured in multiple oral presentations at the Bascom Palmer Eye Institute’s Angiogenesis, Exudation, and Degeneration 2002 Virtual Event to be held February 11-12, 2022.

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients.

IsoPlexis, the Superhuman Cell Company, announced the opening of its first office in the Asia-Pacific region headed by Jason Ou as President/General Manager, APAC Region.

Prelude Corporation today announced that it has appointed Derek J. Maetzold , Founder, President and Chief Executive Officer of Castle Biosciences, Inc. to the Company’s Board of Directors, effective immediately.

NanoMosaic Inc. has announced that it has officially opened its “Proteomics/Multi-Omics Early Access Program,” to life science researchers and to CLIA certified labs.

Deciphera Pharmaceuticals, Inc. announced that Steve Hoerter, President and Chief Executive Officer, will present virtually at the following investor conferences.